Browse result page of THPdb

The total number entries retrieved from this search are 58

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1741	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandNA	CompanyNA	Physical AppearanceInjection, Solution; Injection	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 9
ID1742	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 10
ID1743	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 11
ID1744	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 12
ID1811	ThPPIDTh1202	NamePembrolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length711	Functional ClassificationIIIc	DiseaseCancer	BrandKeytruda	CompanyMerck Sharp & Dohme Corp.	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1815	ThPPIDTh1206	NameNivolumab	Peptide SequenceHeavy Chain Sequence Full view	Length710	Functional ClassificationIIIc	DiseaseCancer	BrandOpdivo	CompanyE.R. Squibb & Sons, L.L.C.	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1821	ThPPIDTh1212	NameInsulin Pork	Peptide SequenceA chain GIVEQCCTSICS Full view	Length68	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandIletin II	CompanyLilly	Physical Appearancesterile suspension	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents, Antidiabetic Agents	TargetInsulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2
ID1829	ThPPIDTh1219	NameAnti-thymocyte Globulin (Rabbit)	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandATG-Fresenius	CompanyGenzyme Inc.	Physical AppearanceConcentrate for solution for infusion.	Route of Administartion Intravenous	CategoryAntibody	TargetT-cell surface glycoprotein CD1a, Major histocompatibility complex class I-related gene protein, Integrin alpha-L, T-lymphocyte activation antigen CD86, Low affinity immunoglobulin gamma Fc region receptor II-b, T-cell surface glycoprotein CD4, Integrin beta-1, Integrin alpha-V, Integrin beta-3